Amy E. Halseth
Avidity (United States)(US)
Publications by Year
Research Areas
Muscle metabolism and nutrition, Adipose Tissue and Metabolism, Diet and metabolism studies, Metabolism, Diabetes, and Cancer, Pharmacology and Obesity Treatment
Most-Cited Works
- → Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes(2005)299 cited
- → Progressive Reduction in Body Weight after Treatment with the Amylin Analog Pramlintide in Obese Subjects: A Phase 2, Randomized, Placebo-Controlled, Dose-Escalation Study(2007)178 cited
- → Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity(2008)169 cited
- → Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study(2007)128 cited
- → Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo(1999)104 cited
- → Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial(2010)95 cited
- → Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats(1994)86 cited
- → Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations(2002)68 cited
- → Mathematical Modeling Shows Exenatide Improved β-Cell Function in Patients with Type 2 Diabetes Treated with Metformin or Metformin and a Sulfonylurea(2006)62 cited
- → Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat(2000)57 cited